CHU Lille, Critical Care Center, rue E. Laine, 59037, Lille cedex, France.
Department of Medical Intensive Care, Rouen University Hospital, and UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France.
Intensive Care Med. 2017 Nov;43(11):1562-1571. doi: 10.1007/s00134-017-4736-x. Epub 2017 Mar 16.
Studies on the impact of tapered-cuff tracheal tubes on rates of microaspiration and ventilator-associated pneumonia (VAP) in intubated patients have reported conflicting results. The aim of this study was to determine the influence of this shape of tracheal cuff on abundant microaspiration of gastric contents in critically ill patients.
All patients intubated in the intensive care unit (ICU) and requiring mechanical ventilation for at least 48 h were eligible for this multicenter cluster-randomized controlled cross-over open-label study. The primary outcome was abundant microaspiration of gastric contents, defined by the presence of pepsin at significant level in >30% of tracheal aspirates. Quantitative measurement of pepsin and salivary amylase was performed in all tracheal aspirates during the 48 h following enrollment.
A total of 326 patients were enrolled in the ten participating ICUs (162 in the PVC tapered-cuff group and 164 in the standard-cuff group). Patient characteristics were similar in the two study groups. The proportion of patients with abundant microaspiration of gastric contents was 53.5% in the tapered-cuff and 51.0% in the standard-cuff group (odds ratio 1.14, 95% CI 0.72-1.82). While abundant microaspiration of oropharyngeal secretions was not significantly different (77.4 vs 68.6%, p = 0.095), the proportion of patients with tracheobronchial colonization was significantly lower (29.6 vs 43.3%, p = 0.01) in the tapered-cuff than in the standard-cuff group. No significant difference between the two groups was found for other secondary outcomes, including ventilator-associated events and VAP.
This trial showed no significant impact of tapered-cuff tracheal tubes on abundant microaspiration of gastric contents.
ClinicalTrials.gov, number NCT01948635.
关于锥形套囊气管导管对插管患者微吸入和呼吸机相关性肺炎(VAP)发生率影响的研究结果相互矛盾。本研究旨在确定这种气管套囊形状对危重症患者大量胃内容物微吸入的影响。
所有在重症监护病房(ICU)插管并需要机械通气至少 48 小时的患者均符合这项多中心集群随机对照交叉开放标签研究的入选标准。主要结局为大量胃内容物微吸入,定义为气管抽吸物中胃蛋白酶含量显著升高且超过 30%。所有患者在入组后 48 小时内均进行了气管抽吸物中胃蛋白酶和唾液淀粉酶的定量测量。
共有 326 名患者入组参加了十个 ICU 的研究(锥形套囊组 162 例,标准套囊组 164 例)。两组患者的特征相似。锥形套囊组中有 53.5%的患者存在大量胃内容物微吸入,标准套囊组中有 51.0%(比值比 1.14,95%CI 0.72-1.82)。虽然口咽分泌物大量微吸入差异无统计学意义(77.4%比 68.6%,p=0.095),但锥形套囊组的气管支气管定植比例明显低于标准套囊组(29.6%比 43.3%,p=0.01)。两组间其他次要结局,包括呼吸机相关性事件和 VAP,均无显著差异。
本试验表明锥形套囊气管导管对胃内容物大量微吸入无显著影响。
ClinicalTrials.gov,编号 NCT01948635。